A Potent Cyclooxygenase-2 Inhibitor for Synthesized Pyrimidine and Thiazolopyrimidine Derivatives

被引：5
|
作者：
Amr, Abd El-Galil E. [1 ,2 ]
Al-Omar, Mohamed A. [1 ]
Abdalla, Mohamed M. [3 ]
机构：
[1] King Saud Univ, Coll Pharm, DEDC, Dept Pharmaceut Chem, Riyadh 11451, Saudi Arabia
[2] Natl Res Ctr, Dept Appl Chem, Cairo, Egypt
[3] Saco Pharm Co, Res Unit, 6th October City 11632, Egypt
来源：
INTERNATIONAL JOURNAL OF PHARMACOLOGY | 2016年 / 12卷 / 02期
关键词：
Pyridine derivatives; thiazolopyrimidine; anti-inflammatory activities; COX-2; inhibitors; ANALGESIC ACTIVITY EVALUATION; ANTIINFLAMMATORY ACTIVITY; BIOLOGICAL EVALUATION; ANTICANCER; DESIGN;
D O I：
10.3923/ijp.2016.86.91
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Ten pyridine and pyrimidine and thiazolopyrimidine derivatives (1-10) were synthesized and screened as analgesic, anticonvulsant and antiparkinsonian agent before. Herein, all the target compounds showed anti-inflammatory activity. The active compounds showed selective inhibitory activity towards COX-2 enzyme as revealed by the in vitro enzymatic assay. All the tested compounds proved to have superior gastrointestinal (GI) safety profiles as compared to indomethacin, when tested for their ulcerogenic effects.
引用
收藏
页码：86 / 91
页数：6
相关论文
共 50 条
  • [31] Cyclooxygenase-2 Inhibitor: A Potential Combination Strategy With Immunotherapy in Cancer
    Pu, Dan
    Yin, Liyuan
    Huang, Lin
    Qin, Changlong
    Zhou, Yuwen
    Wu, Qiang
    Li, Yan
    Zhou, Qinghua
    Li, Lu
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [32] Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2
    King, J. N.
    Dawson, J.
    Esser, R. E.
    Fujimoto, R.
    Kimble, E. F.
    Maniara, W.
    Marshall, P. J.
    O'Byrne, L.
    Quadros, E.
    Toutain, P. L.
    Lees, P.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2009, 32 (01) : 1 - 17
  • [33] Potent and selective cyclooxygenase-2 inhibitors from three structural classes
    不详
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1999, 9 (01) : 101 - 103
  • [34] Inhibition of Bacterial Multidrug Resistance by Celecoxib, a Cyclooxygenase-2 Inhibitor
    Kalle, Arunasree M.
    Rizvi, Arshad
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (01) : 439 - 442
  • [35] QSAR of 2-(4-methylsulphonylphenyl) pyrimidine derivatives as cyclooxygenase-2 inhibitors: simple structural fragments as potential modulators of activity
    Sharma, B. K.
    Singh, P.
    Pilania, P.
    Shekhawat, M.
    Prabhakar, Y. S.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2012, 27 (02) : 249 - 260
  • [36] Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2
    Esser, R
    Berry, C
    Du, ZM
    Dawson, J
    Fox, A
    Fujimoto, RA
    Haston, W
    Kimble, EF
    Koehler, J
    Peppard, J
    Quadros, E
    Quintavalla, J
    Toscano, K
    Urban, L
    van Duzer, J
    Zhang, XL
    Zhou, SY
    Marshall, PJ
    BRITISH JOURNAL OF PHARMACOLOGY, 2005, 144 (04) : 538 - 550
  • [37] Anticancer Activity of Selective Cyclooxygenase-2 Inhibitor with Conventional NSAIDs
    Mishra, Debasis
    Ghosh, G.
    Kumar, P. Sudhir
    Panda, P. K.
    ASIAN JOURNAL OF CHEMISTRY, 2011, 23 (01) : 427 - 430
  • [38] Modeling the binding modes of stilbene analogs to cyclooxygenase-2: a molecular docking study
    Bouaziz-Terrachet, Souhila
    Toumi-Maouche, Amel
    Maouche, Boubekeur
    Tairi-Kellou, Safia
    JOURNAL OF MOLECULAR MODELING, 2010, 16 (12) : 1919 - 1929
  • [39] A sulfonimide derivative of bezafibrate as a dual inhibitor of cyclooxygenase-2 and PPARα
    Ammazzalorso, Alessandra
    Tacconelli, Stefania
    Contursi, Annalisa
    Hofling, Ulrika
    Cerchia, Carmen
    Di Berardino, Sara
    De Michele, Alessandra
    Amoroso, Rosa
    Lavecchia, Antonio
    Patrignani, Paola
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [40] Novel selective inhibitors of hydroxyxanthone derivatives for human cyclooxygenase-2
    Chen, Yu-chian
    Chen, Kun-tze
    ACTA PHARMACOLOGICA SINICA, 2007, 28 (12) : 2027 - 2032
12345